Randomised double-blind placebo-controlled trial of intravenous antioxidant therapy in predicted severe pancreatitis

ISRCTN ISRCTN56033334
DOI https://doi.org/10.1186/ISRCTN56033334
Secondary identifying numbers N0226121484
Submission date
12/09/2003
Registration date
12/09/2003
Last edited
27/04/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Digestive System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr Simon Galloway
Scientific

Department of Surgery
South Manchester University Hospitals NHS Trust
Wythenshawe Hospital
Southmoor Road
Manchester
M23 9LT
United Kingdom

Phone +44 (0)161 291 2404/5
Email Simon.Galloway@smuht.nwest.nhs.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesEither anti-oxidants are of benefit in acute pancreatitis in which case all patients with severe disease should have the benefit of this therapy or they are of no benefit and should no longer be used.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedPancreatitis
InterventionMulti-centre, randomised double-blind placebo-controlled trial:
Group A - Maximal conventional therapy plus intravenous anti-oxidants for 7 days
Group B - Maximal conventional therapy plus placebo
Intervention typeSupplement
Primary outcome measureChange in multiple organ dysfunction score.
Secondary outcome measuresNot provided at time of registration
Overall study start date03/02/2003
Completion date03/02/2005

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants225
Key inclusion criteriaIn total 150 patients with predicted severe acute pancreatitis and approx 75 controls will be recruited over the four centres. Approximately 30 patients at SMUHT.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment03/02/2003
Date of final enrolment03/02/2005

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Department of Surgery
Manchester
M23 9LT
United Kingdom

Sponsor information

Department of Health (UK)
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.doh.gov.uk

Funders

Funder type

Government

South Manchester University Hospitals NHS Trust (SMUHT) (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 01/10/2007 Yes No